Integra Lifesciences Holdings Corp
IART· Nasdaq
IARTIntegra Lifesciences Holdings Corp
Source filing unavailable
| Metric | Q3 2010 | Q3 2009 |
|---|---|---|
| Revenue | $186.64M | $172.29M |
| Net Income | $16.48M | $14.43M |
| EPS Diluted | $0.55 | $0.49 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR
